Examinant per Autoria "Salar Silvestre, Antonio"
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert A phase II study to evaluate lenalidomide in combination with metronomic-dose cyclophosphamide in patients with heavily pretreated classical Hodgkin lymphoma.(Informa Healthcare , 2015) Rueda, Antonio; García-Sanz, Ramón; Pastor, Miguel; Salar Silvestre, Antonio; Labrador, Jorge; Quero-Blanco, Cristina; Casanova, María; Provencio, Mariano; Gotel and Geltamo
Ítem Accés Obert Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort study(Wiley, 2023) Ródenas-Quiñonero, Isabel; Salar Silvestre, Antonio; Suárez-Piñera, Marina; Ortuño, Francisco José
Ítem Accés Obert Analysis of personality traits in patients with hodgkin lymphoma(MDPI, 2021) Roso-Bas, Fátima; Alonso-Llobregat, Maria Dolores; Bento, Leyre; Sánchez González, Blanca; Herraez, Ines; Garcia-Dilla, Pilar; Vallespir, Catalina; Rado, Francesca; Rodriguez, Raquel; Garcia Pallarols, Francesc; Aguirre, Irache; Bargay, Joan; Sampol, Antonia; Salar Silvestre, Antonio; Gutierrez, Antonio
Ítem Accés Obert Anthracycline-induced cardiotoxicity in diffuse large B-cell lymphoma: NT-proBNP and cardiovascular score for risk stratification(Wiley, 2019) Gimeno Vázquez, Eva; Subirana Cachinero, Isaac; Gómez Pérez, Miguel Angel; Díaz, Javier; Sanchez Gonzalez, Blanca; García-Pallarols, Francesc; Martínez, Laia; Ble, Mireia; Molina Ferragut, Luis; Belarte Tornero, Laia Carla; Abella Monreal, Eugenia; Elosua Llanos, Roberto; Comín Colet, Josep; Salar Silvestre, Antonio
Ítem Accés Obert Anti-tumor activity of the combination of bendamustine with vorinostat in diffuse large B-cell lymphoma cells.(Taylor & Francis, 2016) Fernández Rodríguez, M. Concepción; Salar Silvestre, Antonio; Navarro, Alfons; Gimeno Vázquez, Eva; Pairet García, Silvia; Camacho Díaz, Laura; Ferraro Rosset, Mariana Paola; Serrano Figueras, Sergi; Besses Raebel, Carles; Bellosillo Paricio, Beatriz; Sanchez Gonzalez, Blanca
Ítem Accés Obert Aplastic Anemia and Severe Myelosuppression with Boceprevir or Simeprevir-Containing Hepatitis C Virus Treatment(Asociación Mexicana de Hepatología, 2017) Senín Magan, Maria Alicia; Broquetas, Teresa; Cañete Hidalgo, Nuria; Lens, Sabela; Londoño, María-Carlota; Ferraro Rosset, Mariana Paola; Forns, Xavier; Salar Silvestre, Antonio; Carrión Rodríguez, José Antonio
Ítem Accés Obert Attitudes of physicians toward assessing risk and using granulocyte colony-stimulating factor as primary prophylaxis in patients receiving chemotherapy associated with an intermediate risk of febrile neutropenia.(Springer, 2015) Freyer, Gilles; Kalinka-Warzocha, Ewa; Syrigos, Konstantinos; Marinca, Mihai; Tonini, Giuseppe; Ng, Say Liang; Wong, Zee Wan; Salar Silvestre, Antonio; Steger, Guenther; Abdelsalam, Mahmoud; DeCosta, Lucy; Szabo, Zsolt
Ítem Accés Obert Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab Exposure(Elsevier, 2017) Jiménez-Ubieto, Ana; Salar Silvestre, Antonio; Lahuerta, Juan José; Spanish Lymphoma Group (GELTAMO)
Ítem Accés Obert Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapy(Elsevier, 2019) Salar Silvestre, Antonio; Jiménez-Ubieto, Ana; Lahuerta, Juan José; GELTAMO Group
Ítem Accés Obert Best treatment option for patients with refractory aggressive B-cell lymphoma in the CAR-T cell era: real-world evidence from GELTAMO/GETH Spanish Groups(Frontiers, 2022) Bastos Oreiro, Mariana; Salar Silvestre, Antonio; Martin, Alejandro
Ítem Accés Obert Case report: High doses of intravenous immunoglobulins as a successful treatment for late onset immune agranulocytosis after rituximab plus bendamustine(Frontiers, 2022) Díez-Feijóo, Ramón; Rodríguez-Sevilla, Juan José; Fernández Rodríguez, M. Concepción; Flores, Solange; Raya, Carmen; Ferrer, Ana; Colomo Saperas, Luis Alberto; Salar Silvestre, Antonio
Ítem Accés Obert CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma(Frontiers, 2024) Hontecillas-Prieto, Lourdes; Salar Silvestre, Antonio; Cruz-Merino, Luis
Ítem Accés Obert Cell-Free DNA as a biomarker at diagnosis and follow-up in 256 B and T-Cell lymphomas(MDPI, 2024) Díez-Feijóo, Ramón; Andrade-Campos, Marcio; Gibert Fernandez, Joan, 1988-; Sánchez González, Blanca; Fernández-Ibarrondo, Lierni; Fernández Rodríguez, M. Concepción; García Gisbert, Nieves, 1994-; Camacho Díaz, Laura; Lafuente, Marta; Vázquez, Ivonne; Colomo Saperas, Luis Alberto; Salar Silvestre, Antonio; Bellosillo Paricio, Beatriz
Ítem Accés Obert Cell-free DNA for genomic analysis in primary mediastinal large B-cell lymphoma(MDPI, 2022) Rivas-Delgado, Alfredo; Nadeu, Ferran; Andrade-Campos, Marcio; López, Cristina; Enjuanes¸ Anna; Mozas, Pablo; Frigola, Gerard; Colomo Saperas, Luis Alberto; Sánchez González, Blanca; Villamor, Neus; Beà, Sílvia; Campo, Elias; Salar Silvestre, Antonio; Giné, Eva; López Guillermo, Armando; Bellosillo Paricio, Beatriz
Ítem Accés Obert Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial.(Springer Verlag, 2016) González-Barca, E.; Canales, M.; Salar Silvestre, Antonio; Ferreiro-Martínez, J. J.; Ferrer-Bordes, S.; García-Marco, J. A.; Sánchez-Blanco, J. J.; García-Frade, Javier; Peñalver, Francisco-Javier; Bello-López, J. L.; Sancho, José María; Caballero, Dolores; GELTAMO Group
Ítem Accés Obert Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial(BMJ Publishing Group, 2021) Jiménez-Cortegana, Carlos; Salar Silvestre, Antonio; Cruz-Merino, Luis
Ítem Accés Obert Clinical interest of LMO2 testing for the diagnosis of aggressive large B-Cell lymphomas(MDPI, 2020) Vazquez de las Heras, Ivonne; Papaleo, Natalia; García, Eugenia; Salido Galeote, Marta; Salar Silvestre, Antonio; Hernández Llodrà, Silvia; Calvo Gonzalo, Xavier; Colomo Saperas, Luis Alberto
Ítem Accés Obert Comparing R-Bendamustine vs. R-CHOP Plus maintenance therapy as first-line systemic treatment in follicular lymphoma: A multicenter retrospective GELTAMO study(MDPI, 2024) Bastos Oreiro, Mariana; Salar Silvestre, Antonio; Sancho, Juan Manuel
Ítem Accés Obert Cost-effectiveness analysis of bendamustine plus rituximab as a first-line treatment for patients with follicular lymphoma in Spain.(Springer, 2016) Sabater, Eliazar; López Guillermo, Armando; Rueda, Antonio; Salar Silvestre, Antonio; Oyagüez, Itziar; Collar, Juan Manuel
Ítem Accés Obert Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study(SpringerOpen, 2021) Link, Hartmut; Illerhaus, G.; Martens, U.M.; Salar Silvestre, Antonio; Depenbusch, R.; Köhler, A.; Engelhardt, M.; Mahlmann, S.; Zaiss, M.; Lammerich, A.; Bias, P.; Buchner, A.
- «
- 1 (current)
- 2
- 3
- »